Atlas Trials

ONL Therapeutics

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch ONL Therapeutics

RecordFirmDate
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD (NCT06659445)ONL Therapeutics2025-10-28
A Phase 2 Study to Assess the Safety and Efficacy of Intravitreal ONL1204 Ophthalmic Solution in Subjects With Mac-off Retinal Detachment (NCT05730218)ONL Therapeutics2023-04-04
A Phase 1b Study of ONL1204 Ophthalmic Solution in Patients with Progressing Open Angle Glaucoma (NCT05160805)ONL Therapeutics2022-05-02
ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration (NCT04744662)ONL Therapeutics2021-07-08
A Study to Evaluate the Safety and Tolerability of ONL1204 in Patients With Macula-off, Rhegmatogenous Retinal Detachment (NCT03780972)ONL Therapeutics2019-10-21

Track ONL Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.